Diabetes, Heart, and Cardiovascular Diseases News Chronicle.      Article 68

A Study On Occurrence Of Type 1 Diabetes

Know how to reverse type 2 diabetes.
Ad

A study led by Dr. Nicholas JM Thomas from the University of Exeter Medical School, Exeter, Devon, United Kingdom found that 50 percent of the type 1 diabetes (T1D) cases were developed after 30 years. Researchers reviewed the data from the UK Biobank and the results negate the belief that type 1 diabetes develops in childhood. Researchers found that

  • Almost all diabetes cases below 30 years were of type 1 diabetes (T1D)
  • Incidents of type 2 diabetes (T2D) increases with increasing age
  • Number of type 1 diabetes (T1D) cases remained constant from 30 to 60 years and 50 percent of the cases reported after 30 years

Ad Reverse your type 2 diabetes in three weeks or less!
See More Ads For "Reversal Of Diabetes"

The study findings were presented to the European Association for the Study of Diabetes (EASD).



        Twitter
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


Ad A simple diabetic nerve pain treatment program
See More Ads For "Cure To Diabetic Pain"

1. About type 1 disease (T1D) And type 2 Diabetes (T2D)
2. Device To Release Drugs In Eye
3. Treatment With Patient Specific Drugs
4. Chronic Kidney Disease, Heart Disease & Diabetes Prevention Drugs From Forxiga Drug Maker AstraZeneca

 

FDA Approves Medtronic Artificial Pancreas MiniMed 670G

Ad

Food and Drug Administration (FDA) approved MiniMed 670G artificial pancreas device made by Medtronic. Medtronic filed for FDA approval of MiniMed in June 2016. The product will be in the market during spring of 2017.


Ad The proven 3-point method to melt away ugly body fat in just 15 minutes a day
See More Ads For "Lowering Body Fat"



        Twitter
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


Ad Use this simple trick to melt over 40 pounds of belly fat
See More Ads For "Lowering Body Fat"

1. FDA Approval Of Adlyxin
2. About Medtronic Sugar.IQ
3. Risk To Pancreas Inflammation With Gliptin Treatment
4. About Medtronic MiniMed 630G

 

DPP-4 Inhibitor Linagliptin Tradjenta Prevents Cardiovascular Disease (CVD)

Ad

Previous studies show that overweight and high blood sugar levels cause vascular stiffness (network blood vessels stiffness) and progression of cardiovascular disease (CVD). Women are at an enhanced risk compared to men of same age and same health problems. Researchers from University of Missouri School of Medicine observed in mice models that linagliptin diabetes drug is preventing vascular stiffness in obese female mice. Researchers say further research is required to confirm results. Lead author of the study is Dr. Vincent DeMarco, an associate professor at MU School of Medicine.


Ad Eliminate cholesterol plaque buildup in your arteries without medications
See More Ads For "Lowering Cholesterol"


Ad Gluten and dairy free Bowtrol probiotic supplement to restore digestive gut bacteria and the immune system
See More Ads For "Probiotic"



        Twitter
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


Ad Reverse the risk of heart diseases. Get normal levels of blood pressure and cholesterol
See More Ads For "Lowering Blood Pressure"

1. Trials Of Tradjenta Linagliptin Drug
2. Cardiovascular Exercise Benefits With Interval Exercise training
3. Dyslipidemia And Risks To Cardiovascular Disease (CVD) And Ischemic Heart Disease (IHD)
4. Device To Detect Deadly Ketones

 

Linagliptin : Trade names are Tradjenta in the United States and Trajenta in other countries. This is a prescription based DPP-4 inhibitor and diabetes drug developed by Boehringer Ingelheim to lower blood sugar levels in type 2 diabetes (T2D) patients. This drug blocks enzyme dipeptidyl peptidase-4 or DPP-four to lower blood sugar levels. An earlier study show that this drug prevents arterial stiffening conditions such as vascular inflammation.

Regular Cycling Prevents Type 2 Diabetes (T2D) And Coronary Heart Disease

Ad

A research study results linked cycling exercise to a lower risk of development of type 2 diabetes (T2D). Researchers studied about 24,000 men and 28,000 women aged between 50 and 65 years in Denmark and came to following conclusions.

  • Individuals who do cycling regularly were less likely to develop type 2 diabetes (T2D)
  • The risk of type 2 diabetes (T2D) decreases as hours spent on cycling increases
  • The risk of type 2 diabetes (T2D) was reduced by 20 percent in those individuals who started cycling for the past five years compared with non-cycling individuals

Ad Lightning speed fitness program to improve your fitness without gyms in 15-minutes a day or less
See More Ads For "Abs Workout Routine"

The study results were published in PLOS Medicine Journal. British Medical Association says cycling for 20 miles or 32 km per week reduces the risk of coronary heart disease by 50 percent and improves quality of life.


Ad Develop a stunning set of six pack abs. Gain muscle strength and tone and beach-ready body.
See More Ads For "Abs Workout Routine"



        Twitter
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


Ad Strip away your excess belly fat and feel 10 years younger!
See More Ads For "Abs Workout Routine"

1. Study With Standing, Sitting and Cycling Activity
2. Tips To Manage Type 2 Diabetes (T2D)
3. Coronary Artery Disease And Risks To Coronary Artery Calcification (CAC) Score
4. About Revita DMR Device

 

Link Between LDL-C Drugs And type 2 Diabetes

Ad

Researchers studied meta-analysis of more than 500,000 adults and found that variants near NPC1L1, PCSK9 and HMGCR and other genes associated with a reduction of low-density lipoprotein cholesterol (LDL-C) were linked to adverse metabolic consequences and enhanced risk of type 2 diabetes (and weight gain). But researchers say the risk of coronary heart disease will decrease. LDL-C is a "BAD" cholesterol and is the main cause of the development of plaque in the arteries, a risk factor for heart diseases and stroke. Some of the LDL-C lowering drugs in the market are ezetimibe, statins and PCSK9-inhibitors. Senior author of the study is Dr. Luca A Lotta of the University of Cambridge, UK and the study results were published in JAMA.


Ad A science-based plan to melt away stubborn body fat in just 14 days
See More Ads For "Lowering Body Fat"


Ad Evidence shows 297% increased fat loss without painful diets or increasing exercise
See More Ads For "Lowering Body Fat"



        Twitter
Post a message on social media and mail to your friend and doctor to resolve your health condition. Article address TO LINK on your social media is (copy and paste the code below) :

Articles similar to this topic


Ad A New Way To Lower Your Blood Sugar & Improve Your Kidney Function
See More Ads For "Reversal Of Diabetes"

1. Study On Wearable Technology Devices
2. Device To Find Out Internal Inflammation
3. Diabetes Mobile App To Manage Blood Sugar Levels
4. Factors To Prevent Heart Attack

 

Stroke : Also called as brain attack is caused due to high blood pressure that damages arteries (atherosclerosis and hardening) in the body. Deteriorated arteries in the brain obstruct the flow of blood to brain cells. Cells in the brain die due to non-availability of oxygen and glucose and cause permanent damage to the brain. High blood pressure increases stroke the risk by four to six times. Most of the strokes are ischemic strokes.

 

Published on October 8, 2016

 


The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. The published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.


Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.